BioAdvance
The Biotechnology Greenhouse of Southeastern PA
3701 Market Street
Philadelphia
Pennsylvania
19104
United States
Tel: 215-966-6214
Fax: 215-966-6215
Website: http://www.bioadvance.com/
Email: info@bioadvance.com
24 articles about BioAdvance
-
Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease
8/14/2019
Renovacor, Inc announced the successful completion of an $11 million Series A financing co-led by Novartis Venture Fund, Broadview Ventures, and BioAdvance, and joined by New Leaf Venture Partners and Innogest Capital.
-
Velano Vascular Adds Healthcare Veterans David R. Strand and Dr. Gary Kurtzman to Board of Directors
8/1/2018
Vascular access technology innovator Velano Vascular today welcomed Safeguard Scientifics Healthcare Managing Director, Gary Kurtzman, MD and seasoned Chief Executive Officer and former hospital system Chief Operating Officer David R. Strand to its Board of Directors.
-
BioAdvance Commits $3.2M to Life Sciences Companies in First Six Months of FY 2018
1/16/2018
These investments represent a commitment of $3.2M to the success and growth of life science companies in the mid-Atlantic region.
-
BioAdvance Commits $4M To 14 Life Sciences Companies
8/14/2017
-
BioAdvance Commits $2.9M To 15 Life Sciences Companies
7/27/2016
-
BioAdvance Release: First Ever Life Sciences Ecosystem Interactive Map Launched In Pennsylvania
10/28/2015
-
BioAdvance Portfolio Companies Attract $85 Million Of Capital In 12 Months
6/11/2015
-
BioAdvance Expands Team to Support Portfolio Companies and New Investments
10/16/2012
-
BioAdvance Announces Investment Activity in PA Life Science Companies
6/19/2012
-
BioAdvance Release: Merganser Biotech Announces Signing of Option to License Minihepcidin Technology from University of California, Los Angeles (UCLA)
12/12/2011
-
BioAdvance Names Sam Katz as Chair and Elects J. Larry Jameson, M.D., Ph.D., and Lauren Lenfest as Directors
11/15/2011
-
QR Pharma Completes $2.4 Million Seed Financing with Round-Closing Investments from BioAdvance and Angels to Advance Clinical Development of two Alzheimer’s Disease Compounds
6/2/2010
-
BioAdvance Expands Team to Support Portfolio and Future Investments
9/22/2009
-
BioAdvance Funds TREVENTIS to Advance Alzheimer's Drug Discovery
8/10/2009
-
BioAdvance Names Dr. Philip P. Gerbino Chair and Elects Dr. John M. Daly to Board of Directors
4/16/2009
-
BioAdvance Announces Seed-Stage Investment in Novira Therapeutics to Advance Antiviral Drug Discovery
3/30/2009
-
BioAdvance Greenhouse Fund Commits $1.5 Million in Seed Financing to Three Regional Life Science Companies
9/12/2008
-
BioAdvance Announces New Board Chairman
11/28/2006
-
BioAdvance Launches Rolling Process For Life Sciences Businesses Seeking Early-Stage Investment
10/16/2006
-
BioAdvance Invests In Midway Pharmaceuticals To Support Promising Development Program For GI Therapies
5/17/2006